Cite
Advanced Age at Transplant Increases the Risk of Second Solid Malignancy (SSM) after Haematopoetic Stem Cell Transplantation (HSCT)
MLA
Adrian Bloor, et al. “Advanced Age at Transplant Increases the Risk of Second Solid Malignancy (SSM) after Haematopoetic Stem Cell Transplantation (HSCT).” Blood, vol. 124, Dec. 2014, p. 3952. EBSCOhost, https://doi.org/10.1182/blood.v124.21.3952.3952.
APA
Adrian Bloor, Tim C. P. Somervaille, John Eliott, John J. Murray, Jim Cavet, Rachel Brown, Siobhan Muthia, Angie Leather, Samar Kulkarni, Rita Angelica, Michael Dennis, John A. Chadwick, Jo Tomlins, & Sven Armin Sommerfeld. (2014). Advanced Age at Transplant Increases the Risk of Second Solid Malignancy (SSM) after Haematopoetic Stem Cell Transplantation (HSCT). Blood, 124, 3952. https://doi.org/10.1182/blood.v124.21.3952.3952
Chicago
Adrian Bloor, Tim C. P. Somervaille, John Eliott, John J. Murray, Jim Cavet, Rachel Brown, Siobhan Muthia, et al. 2014. “Advanced Age at Transplant Increases the Risk of Second Solid Malignancy (SSM) after Haematopoetic Stem Cell Transplantation (HSCT).” Blood 124 (December): 3952. doi:10.1182/blood.v124.21.3952.3952.